Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, B-Cell × navitoclax × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Primary Myelofibrosis 2 Myelodysplastic Syndromes 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Melanoma 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 5 fludarabine 4 ibrutinib 3 acalabrutinib 3 Mycophenolic Acid 3 Mesna 3 Melphalan 3 venetoclax 2 pirtobrutinib 2 obinutuzumab 2 Whole-Body Irradiation 2 Tacrolimus 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Busulfan 2 Bone Marrow Transplantation 2 ARQ531 2 zanubrutinib 1 ricolinostat 1 idelalisib 1 idecabtagene vicleucel 1 Vincristine 1 Stem Cell Transplantation 1 Rabeprazole 1 Prednisone 1 Magnetic Resonance Imaging 1 Leukapheresis 1 Itraconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡